All notifications at a glance

Following Geratherm Medical AG's 20% stake in BIOThermare, a young company that produces environmentally friendly cold/warm compresses with a patented algae gel filling, another update was published…

The sale of apoplex medical technologies GmbH to a German-American consortium was successfully concluded as agreed and the pro rata purchase price was paid in full.

On October 30, 2024, the price target was updated following the announcement of the extension of short-time work at the Geratal site. ResearchHub continues to issue a Buy recommendation for the…

Another step in the realignment of Geratherm Medical AG has been taken. Geratherm Medical AG acquires 20% of the shares in BIOThermare GmbH, Obermichelbach.

BIOThermare GmbH is a leading manufacturer…

Due to the ongoing difficult market situation, short-time working at the Geratal site for clinical thermometer production will be extended until March 31, 2025.

The other divisions of the Geratherm…

Geratal, September 18, 2024. The realignment of Geratherm Medical AG has begun. Geratherm Medical AG sells 100% of its 60.55% stake in apoplex medical technologies together with the other shareholders…

On June 26, 2024, Alster Research published another update on the Geratherm Group, whereby the ongoing challenges in the Healthcare Diagnostic environment and a weak first half of the year have…

As a result of the mild winter and increased demand during the coronavirus pandemic, demand for clinical thermometers is currently below average. For this reason and in order to reduce inventories, we…

Due to the mild winter, the sale of clinical thermometers is under plan at the moment. Its currently not possible to make a forecast for the whole year.
To reduce inventories, short-time-working will…

Geratal, February 7, 2024. The Supervisory Board and Management Board have extended the current Management Board contract by a further 3 years until December 31, 2027 in order to continue to ensure…